Avanos Medical financials at a glance

+ Portfolio

The revenue of Avanos Medical is reported as 0.6733 billion Dollars in the fiscal year 2023. The earnings were 1.38 Dollars per share in 2023, which was 16.36 lower than 2022. And about 0.0146 billion Dollars are reported as free cash flow in the financials of Avanos Medical 2023. No dividends were paid to the shareholders of the Avanos Medical stock NYSE:AVNS in the financial year 2023.

$673.30M

Revenue

$1.38

Earnings Per Share

56.39%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

673.30

Earnings Per Share

1.38

Gross Margin %

56.39

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Rev.	Revenue	N/A	$673.30M	$820.00M	$744.60M	$714.80M	$697.60M	$652.30M	$1.62B	$1.59B	$1.57B	$1.67B
GM %	Gross Margin %	54.24%	56.39%	54.88%	49.58%	54.64%	57.65%	59.93%	55.09%	52.49%	50.65%	32.81%
OM	Operating Margin	10.37%	6.79%	9.73%	4.19%	0.83%	-5.82%	1.06%	-7.05%	-18.92%	-23.32%	5.64%
EPS	Earnings Per Share	$-1.19	$1.38	$1.65	$1.15	$0.79	$1.07	$0.82	$2.35	$1.97	$2.11	$4.11
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	43.16M	46.6M	47.32M	47.97M	47.55M	47.31M	46.8M	46.63M	46.59M	46.54M
OCF	Operating Cash Flow	N/A	$32.40M	$90.90M	$87.30M	$-2.50M	$-74.50M	$-,145.60M	$144.20M	$188.80M	$97.60M	$0.00M
FCF	Free Cash Flow	N/A	$14.60M	$71.60M	$66.30M	$-22.70M	$-,125.10M	$-,194.70M	$101.00M	$159.70M	$27.20M	$0.00M
FCFS	Free Cash Flow Per Share	$0.79	$0.31	$1.53	$1.38	$-0.47	$-2.63	$-4.13	$2.16	$3.43	$0.58	$1.49

Avanos Medical financials at a glance

Financials

Discover